Lifecore Biomedical Company Insiders

Lifecore Biomedical Management Team Effectiveness

The company has return on total asset (ROA) of (0.0311) % which means that it has lost $0.0311 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8358) %, meaning that it created substantial loss on money invested by shareholders. Lifecore Biomedical's management efficiency ratios could be used to measure how well Lifecore Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Lifecore Biomedical's Non Currrent Assets Other are relatively stable compared to the past year. As of 07/06/2025, Other Assets is likely to grow to about 25.1 M, while Total Assets are likely to drop slightly above 248.7 M. As of 07/06/2025, Common Stock Shares Outstanding is likely to drop to about 26.4 M. In addition to that, Net Loss is likely to grow to about (87.4 M)

Lifecore Biomedical Workforce Comparison

The company has Profit Margin (PM) of (0.34) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Lifecore Biomedical Insider Trading

Lifecore Biomedical Notable Stakeholders

The success or failure of an entity such as Lifecore Biomedical often depends on how effective the management is. Lifecore Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lifecore management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lifecore management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.